OTC: PAIOF - Paion AG

Rentabilité sur six mois: 0%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Paion AG


À propos de l'entreprise Paion AG

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation.

plus de détails
It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета eur
Сайт https://www.paion.com
Цена ао 0.02
Changement de prix par jour: 0% (0.02)
Changement de prix par semaine: 0% (0.02)
Changement de prix par mois: 0% (0.02)
Changement de prix sur 3 mois: 0% (0.02)
Changement de prix sur six mois: 0% (0.02)
Changement de prix par an: -20.32% (0.0251)
Evolution du prix sur 3 ans: -99.2% (2.5054)
Evolution des prix depuis le début de l'année: 0% (0.02)

Sous-estimation

Nom Signification Grade
P/S 0.8582 9
P/BV 4.31 4
P/E 0 0
EV/EBITDA 8.88 8
Total: 6.13

Efficacité

Nom Signification Grade
ROA, % -1.64 0
ROE, % -9.07 0
Total: 2.17

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA 4.68 1
Total: 7.2

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 1102.07 10
Rentabilité Ebitda, % -134.33 0
Rentabilité EPS, % -55.89 0
Total: 2

Établissements Volume Partager, %
College Retirement Equities Fund-Stock Account 20390 0.29



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Sebastian Werner Member of Management Board & CFO 238.24k
Mr. Tilmann Bur Member of Management Board N/A 1965 (60 années)
Ralf Penner Vice President of Investor Relations & Public Relations N/A
Dr. Thomas Stoehr Senior Vice President of Development N/A
Mr. Gregor Siebert Chairman of Management Board & CEO

Adresse: Germany, Aachen, Heussstrasse 25 - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.paion.com